BACKGROUND: Although @entity158 is the most feared part of the terminal life of many @entity1 with @entity5 , the intensity and the quality of the @entity158 is all too often only scantly described. METHOD: The quality and quantity of @entity158 were prospectively registered by five variables, including a visual analogue scale (VAS), in 46 consecutive @entity1 with exocrine @entity788 . RESULTS: Twenty-seven percent of the @entity1 were @entity158 free and 24 (53%) @entity1 reported little or no @entity158 at the time of diagnosis. Only 5 (11%) @entity1 had severe @entity158 . @entity1 with @entity5 in the head of the pancreas had @entity158 than @entity1 with @entity5 in the body or tail of the pancreas, which could not be explained by stage or size of the @entity5 . With time there were less and less @entity1 with little or no @entity158 (VAS 0-2), but after 8 and 10 weeks about one third of the @entity1 were still without any @entity158 (VAS < or = 0). With time there was also a tendency to treat @entity1 more frequently with @entity1286 in spite of a low @entity158 score. Preoperative @entity158 simply measured with VAS is an addition to prognostic information. CONCLUSION: @entity158 in @entity788 is not as common as usually stated at the time of diagnosis, but is related to the site of the @entity5 . Eventually more @entity1 are treated with opioid drugs. Evaluation of the @entity158 pattern is an addition to prognostic information.

Prospective evaluation of XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancer', 'tumors'] @entity158 :: ('MESH:D010146', 'Disease') :: ['less pain', 'Pain', 'pain', 'completely pain'] @entity1286 :: ('MESH:D009020', 'Chemical') :: ['morphine']
@entity788 :: (MESH:D010190,Disease) :: ['pain in exocrine pancreatic cancer']
